Alula, K.M.; Jackson, D.N.; Smith, A.D.; Kim, D.S.; Turner, K.; Odstrcil, E.; Kaipparettu, B.A.; Dassopoulos, T.; Venuprasad, K.; Feagins, L.A.;
et al. Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease. Cells 2021, 10, 1349.
https://doi.org/10.3390/cells10061349
AMA Style
Alula KM, Jackson DN, Smith AD, Kim DS, Turner K, Odstrcil E, Kaipparettu BA, Dassopoulos T, Venuprasad K, Feagins LA,
et al. Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease. Cells. 2021; 10(6):1349.
https://doi.org/10.3390/cells10061349
Chicago/Turabian Style
Alula, Kibrom M., Dakota N. Jackson, Andrew D. Smith, Daniel S. Kim, Kevin Turner, Elizabeth Odstrcil, Benny A. Kaipparettu, Themistocles Dassopoulos, K. Venuprasad, Linda A. Feagins,
and et al. 2021. "Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease" Cells 10, no. 6: 1349.
https://doi.org/10.3390/cells10061349
APA Style
Alula, K. M., Jackson, D. N., Smith, A. D., Kim, D. S., Turner, K., Odstrcil, E., Kaipparettu, B. A., Dassopoulos, T., Venuprasad, K., Feagins, L. A., & Theiss, A. L.
(2021). Targeting Mitochondrial Damage as a Therapeutic for Ileal Crohn’s Disease. Cells, 10(6), 1349.
https://doi.org/10.3390/cells10061349